The global Cell culture media market generated US$ 3.0 billion in sales in 2022, and is expected to grow at a CAGR of 6.8% to reach US$ 6.3 billion by the end of 2033. In the past seven years, from 2014 to 2021, the global market for cell culture media saw a historic CAGR of 6.1%. Sales of cell culture media made up 19% of the US$16,3 billion global market for cell culture in 2021.
Cell culture is a method of obtaining cells in an in-vitro environment. Normally, nutrient-rich media and a sterile environment are required for cells to thrive. In order to promote cell growth, cell culture mediums are frequently semi-solid, liquid, or gel-based.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/31338
The rising frequency of cancer is one of the major factors driving the cell culture media market expansion. According to the WHO, cancer is the second biggest cause of death. The burden of chronic diseases is rapidly increasing on a global scale. As a result of the rising need for tailored treatment of chronic diseases, which has increased spending on cell culture development, it is predicted that the market for cell culture media would expand.
The number of clinical trials in the biopharmaceutical business and academic research using biopharmaceuticals is rising quickly, as academics are favouring unconventional methods to find novel ways to cure diseases.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/31338
Companies
-
- Becton, Dickinson and Company
- Hi-Media Laboratories
- Merck, KGaA
- STEMCELL Technologies Inc.
- Cell Sciences, Inc.
- GE Healthcare
- PAN Biotech
- MP Biomedicals, LLC.
- PromCell GmbH
- Lonza
- Corning Incorporated
- Irvine Scientific
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/31338
Segments of Cell Culture Media Market Industry Research
By Product:
Serum Containing Media
Serum Free Media
-
- Protein Expression Media
- Stem Cell Media
- Hybridoma Media
- Primary Cell Media
- Insect Cell Media
- Immunology Media
- CHO Cell Culture Media
Protein Free Media
Chemically Defined Media
By Application:
-
- Cancer Research
- Biopharmaceuticals
- Regenerative Medicine & Tissue Engineering
- Stem Cell Technologies
- Others
By End User:
-
- Biopharmaceutical Companies
- Clinical Research Organizations
- Academic Research Centers
By Region:
-
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Competitive Landscape
Leading manufacturers are incorporating effective and efficient media cultures to bolster their product ranges globally. Several significant competitors in the cell culture media sector have carried out similar consolidation actions such as mergers and acquisitions. The expansion of company partnerships to improve their cell culture media in chemotherapeutic research is another important strategy observed in the sector.
-
- In March 2020, the life sciences division of General Electric Company sold the biopharma business to Danaher Corporation (US). The life sciences division of Danaher now manages it as a separate business unit. After being acquired by Danaher, the company is currently known as Cytiva.
- In July 2021, the cell culture authority Xell AG was purchased by Sartorius through its subsidiary Sartorius Stedim Biotech. The company develops, produces, and sells culture and feed additives for cell cultures, primarily for the production of viral vectors used in the production of vaccines and gene therapies.
About Us
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com